Akoya Biosciences Inc (AKYA)
2.42
-0.71
(-22.68%)
USD |
NASDAQ |
Nov 15, 10:49
Akoya Biosciences Cash from Investing (Quarterly): 9.054M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 9.054M |
| March 31, 2024 | -48.82M |
| December 31, 2023 | -0.594M |
| September 30, 2023 | -0.832M |
| June 30, 2023 | -1.423M |
| March 31, 2023 | 6.196M |
| December 31, 2022 | 22.13M |
| September 30, 2022 | 7.266M |
| June 30, 2022 | -42.34M |
| Date | Value |
|---|---|
| March 31, 2022 | -1.138M |
| December 31, 2021 | -1.365M |
| September 30, 2021 | -1.875M |
| June 30, 2021 | -0.947M |
| March 31, 2021 | -0.907M |
| December 31, 2020 | 9.653M |
| September 30, 2020 | -0.902M |
| June 30, 2020 | -0.588M |
| March 31, 2020 | -1.435M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-48.82M
Minimum
Mar 2024
22.13M
Maximum
Dec 2022
-2.714M
Average
-0.9045M
Median
Cash from Investing (Quarterly) Benchmarks
| Bruker Corp | -67.60M |
| Azenta Inc | 201.62M |
| Harvard Bioscience Inc | -1.111M |
| Bionano Genomics Inc | 28.63M |
| Singular Genomics Systems Inc | 23.96M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.04M |
| Cash from Financing (Quarterly) | -2.125M |
| Free Cash Flow | -53.61M |
| Free Cash Flow Per Share (Quarterly) | -0.2269 |
| Free Cash Flow to Equity (Quarterly) | -11.43M |
| Free Cash Flow to Firm (Quarterly) | -9.266M |
| Free Cash Flow Yield | -44.92% |